NASDAQ : IMCC
IM Cannabis Corp. — Key statistics
Healthcare · Drug Manufacturers - Specialty & Generic · Israel
Last price 0.791 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.30M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.30M |
| Enterprise Value | 9.90M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 1.65M |
| Shares Outstanding | 1.65M |
| Shares Change (YoY) | +131.94% |
| Shares Change (QoQ) | +56.30% |
| Owned by Insiders (%) | 12.88% |
| Owned by Institutions (%) | 0.70% |
| Float | 1.08M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.04 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.31 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.56 |
| Quick Ratio | 0.29 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.84 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -18.57% |
| Return on Invested Capital (ROIC) | -68.76% |
| Return on Capital Employed (ROCE) | 209.05% |
| Weighted Average Cost of Capital (WACC) | 28.70% |
| Revenue Per Employee | $733,031 |
| Profits Per Employee | -$286,840 |
| Employee Count | 44 |
| Asset Turnover | 1.39 |
| Inventory Turnover | 12.30 |
Taxes
| Measure | Value |
|---|
| Income Tax | 41,546 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 2.21 |
| 52-Week Price Change | -98.13% |
| 50-Day Moving Average | 2.12 |
| 200-Day Moving Average | 11.16 |
| Relative Strength Index (RSI) | 31.14 |
| Average Volume (20 Days) | 89,685 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 36,121 |
| Short Previous Month | 74,661 |
| Short % of Shares Out | 2.19% |
| Short % of Float | 3.34% |
| Short Ratio (days to cover) | 0.01 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 32.25M |
| Gross Profit | 4.04M |
| Operating Income | -6.88M |
| Pretax Income | -13.04M |
| Net Income | -12.62M |
| EBITDA | -5.66M |
| EBIT | -6.88M |
| Loss Per Share | -$57.94 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 1.14M |
| Total Debt | 9.74M |
| Net Cash | -8.60M |
| Net Cash Per Share | -$5.22 |
| Equity (Book Value) | -3.96M |
| Book Value Per Share | -7.18 |
| Working Capital | -9.20M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -437,878 |
| Capital Expenditures | -10,732 |
| Depreciation & Amortization | 1.24M |
| Net Borrowing | -400,673 |
| Free Cash Flow | -448,610 |
| FCF Per Share | -$0.27 |
Margins
| Measure | Value |
|---|
| Gross Margin | 12.53% |
| Operating Margin | -21.33% |
| Pretax Margin | -40.44% |
| Profit Margin | -39.13% |
| EBITDA Margin | -17.55% |
| EBIT Margin | -21.33% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -131.94% |
| Shareholder Yield | -131.94% |
| Earnings Yield | -7,324.93% |
| FCF Yield | -34.42% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 23.68% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Aug 27, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -15.59 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |